Prep Right
FPSC · CSS 2014

Business Administration

100 marks · 3 hours · 7 questions
This paper Business Administration · all yearsQ. 2 · Discuss the contingency factors that…Q. 3 · What issues do today's leaders…Q. 4 · What constitutes good marketing research?…Q. 5 · How can companies evaluate and…Q. 6 · How is a net present…Q. 7 · How are total risk, non-diversifiable…Q. 8 · The financial statements of Remington…With this paper← 20132015 →
3 hours · questions hide until you reveal them

Not yet checked 1 of 7 questions have not yet been compared with the official paper.

Section A

Q. 2

Discuss the contingency factors that effect planning. Describe how managers can effectively plan in today's environment.

(20)
Q. 3

What issues do today's leaders face? Do you think that most managers in real life use a contingency approach to increase their leadership effectiveness? Explain.

(20)

Section B

Q. 4

What constitutes good marketing research? How can company correctly measure and forecast demand?

(20)
Q. 5

How can companies evaluate and select specific foreign markets to enter? What are the differences between marketing in a developing and developed market?

(20)

Section C

Q. 6

How is a net present value profile used to complete projects? What causes conflicts in making of projects via net present value and internal note of return?

(20)
Q. 7

How are total risk, non-diversifiable risk, and diversifiable risk selected? Why is non-diversifiable risk the only relevant risk?

(20)
Q. 8

The financial statements of Remington Pharmaceuticals for the year ended December 31, 2012, follow: Remington Pharmaceuticals Income Statement for the Year Ended December 31,2012 Sales revenue 160000Less:Costofgoodssold106000Grossprofits 160000 Less: Cost of goods sold 106000 Gross profits 54000 Less Operating expenses Selling expense 16000Generalandadministrativeexpenses10000Leaseexpense1000Depreciationexpense10000Totaloperatingexpense 16000 General and administrative expenses 10000 Lease expense 1000 Depreciation expense 10000 Total operating expense 37000 Operating profits 17000Less:Interestexpense6100Netprofitsbeforetaxes 17000 Less: Interest expense 6100 Net profits before taxes 10900 Less: Taxes 4360 Net Profits after taxes 6540RemingtonPharmaceuticalsBalanceSheet—December31,2012ItemAmount( 6540 Remington Pharmaceuticals Balance Sheet — December 31, 2012 Item Amount () Assets Cash 500 Marketable Securities 1,000 Accounts Receivable 25,000 Inventories 45,500 Total Current Assets 72,000 Land 26,000 Building and Equipment 90,000 Less: Accumulative Depreciation 38,000 Net Fixed Assets 78,000 Total Assets 150,000 Liabilities and Stockholder's Equity Accounts Payable 22,000 Notes Payable 47,000 Total Current Liabilities 69,000 Long Term Debt 22,950 Common Stock Equity 31,500 Retained Earnings 26,550 Total Liabilities and Stockholders Equity 150,000 The firm’s 3000 outstanding shares of common stock closed 2012 at a price of $ 25 per share.

  1. (a)Use the preceding financial statements to complete the following table.
Not yet checked
(20)

Related papers

About this paper

The 2014 CSS Business Administration paper set by the FPSC. Question wording only; questions marked “Not yet checked” have not been compared with the official paper yet.

Disclaimer Prep Right is independent and not affiliated with FPSC.